Related Experiment Videos

Early deaths in Jamaican children with sickle cell disease

Insights

Early diagnosis of sickle cell (SS) disease in Jamaican infants shows 87% two-year survival. Prompt treatment of complications like splenic sequestration and pneumococcal infection is crucial for reducing mortality in these children.

Area of Science:

  • Pediatrics
  • Hematology
  • Genetics

Background:

  • Sickle cell disease (SCD) is a group of inherited red blood cell disorders.
  • Homozygous sickle cell (SS) disease and sickle cell-haemoglobin C (CS) disease are common hemoglobinopathies.
  • Neonatal diagnosis is critical for managing SCD complications.

Purpose of the Study:

  • To evaluate two-year survival rates in Jamaican children diagnosed at birth with SS disease, CS disease, and normal controls.
  • To identify the primary causes of mortality in infants with SS disease.
  • To emphasize the importance of close post-neonatal observation for SCD management.

Main Methods:

  • Retrospective survival analysis of Jamaican children diagnosed neonatally.
  • Comparison of survival rates between SS disease, CS disease, and normal control groups.
  • Analysis of mortality causes in SS disease patients.

Main Results:

  • Two-year survival was 87% for SS disease, 95% for CS disease, and 99% for normal controls.
  • Mortality in SS disease peaked between 6 and 12 months of age.
  • Acute splenic sequestration and pneumococcal infections were the leading causes of death.

Conclusions:

  • Neonatal diagnosis of hemoglobinopathies in Jamaica is associated with improved survival.
  • Close monitoring following neonatal diagnosis is essential to prevent mortality from acute splenic sequestration and pneumococcal infections.
  • Early intervention strategies are vital for improving outcomes in children with sickle cell disease.

Related Concept Videos